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Studies  with  synthetic polypeptide antigens  of  limited  heterogeneity have  con- 
tributed to the realization that genetics plays a  role in the regulation of immune re- 
sponsiveness (1-6). Such genetic control has a  cellular basis, since immune responses 
of mice to synthetic polypepfides derived from multichain polyalanine and responses 
of guinea pigs to conjugates of poly-L-lysine  have been obtained by repopulating the 
immune system of nonresponder animals with lymphoid cells from responders (1, 7, 8). 
Furthermore, phenotypic expression of this type of genetic control of immunity to the 
synthetic polypeptide poly-L-(Tyr, Glu)-poly-L-Pro--poly-L-Lys,  denoted  (T,  G)- 
Pro--L, was recently shown to be reflected in the relative numbers of immunocom- 
petent units  of response detected in  the  spleens of high  and low responder mouse 
strains  (9). About 24  times more limiting precursor cells were detected for this im- 
munogen in spleens of immunized high responder SJL than in those of low responder 
DBA/1 mice. Therefore, the cellular manifestation of genetic regulation of immuno- 
logical responsiveness to (T, G)-Pro--L appears to be due to insufficient numbers of 
relevant precursor cells stimulated by the immunogen under the experimental condi- 
tions used. 
Mozes,  et  al.  reported  genetic  control  of  antibody  specificity for  the  synthetic 
polypeptide  poly-L-(Phe,  Glu)-poly-L-Pro--poly-L-Lys, abbreviated  (Phe,  G)- 
Pro--L (6). DBA/1 mice responded well to the (Phe, G) determinant, but poorly to 
the Pro--L portion of this polypeptide. Conversely, the SJL strain was found to be 
a high responder to Pro--L, but a low responder to (Phe, G). This synthetic immuno- 
gen offers particular advantages for studying a  number of fundamental immunologi- 
cal problems and their possible relationship to  the genetic control of immunological 
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responsiveness. For example, since the two immunopotent portions of the (Phe, G)- 
Pro--L macromolecule appear to be under separate genetic regulation (6),  one can 
systematically investigate the cellular manifestations of this type of genetic control 
in relation to problems such as the recognition of the immunogen, the commitment of 
immunocompetent precursor cells for a given specificity,  the nature of the lymphoid 
organs exhibiting the phenotypic expression of the defect, and the possible significance 
of histocompatibility loci in the development of the immune state. Although some of 
the above immunological  questions have been studied using heterologous erythrocytes 
(10-13),  the large number of determinants contributed by such antigens makes an 
already complex series of events even more difficult to comprehend. 
In the present study, the limiting dilution approach  (9,  14)  was used to es- 
timate the least frequent cell type which constitutes an antigen-sensitive unit 
responsible for  generating  immune responses  specific  for  (Phe,  G)  and  for 
Pro--L in SJL, DBA/1, and F1 mice. With respect to the basic immunological 
problems  outlined  above,  the  findings of  this  report  show  that:  limiting 
dilution analysis can be used for studying the cellular basis of responsiveness 
to  different  immunopotent areas  within  the  same  macromolecule;  different 
populations of  spleen cells limit the  responsiveness to  (Phe,  G)  and Pro--L; 
and  genetic  control  of  responsiveness to  different  determinants attached  to 
poly-L-proline can dramatically alter  the  secondary  response  to  the  Pro--L 
itself. 
Materials and Methods 
Mice.--Inbred  SJL and DBA/1 mice and F~ animals of both sexes, 9-11 wk of age, were 
used as recipients, whereas females of the same age were used as donors. Both inbred mouse 
strains were obtained  from the Jackson Laboratories,  Bar  Harbor,  Maine,  and from the 
Experimental Animal Unit, The Weizmann Institute of  Science. The F1 hybrids of a cross 
between SJL and DBA/1 parents were raised in our department. 
Immunization.--The  immunogen used in this work was poly-L-(Phe,  Glu)-poly-L-Pro-- 
poly-L-Lys,  702, abbreviated  (Phe, G)-Pro--L. The description, synthesis, and character- 
ization of this immunogen have been previously described (15). Immunization of donor and 
recipient mice with (Phe, G)-Pro--L was performed as reported elsewhere (9). 
Irradiation and Cell TransJers.--Recipient mice to be injected with spleen cells were ex- 
posed to 700-800 R of whole body X-irradiation  (250 kv peak, 15 ma, with 0.5 mm of Cu 
"and 1.0 mm A1, source to target distance 50 cm, and exposure rate of 60 R/min) in a rotating 
ucite chamber. Spleen  cell suspensions were prepared and injected into irradiated  syngeneic 
recipients as described elsewhere (9, 14). Nucleated cell counts were made by repeated sample 
counting using a hemocytometer. 
Microhemagglutination Assay.--The  synthetic  polypeptides used for assay were poly-L 
(Try,  Glu)-poly-L-Pro--poly-L-Lys, 701, (T,  G)-Pro--L  (15), and  poly-L-(Phe,  Glu)- 
poly-DL-Ala--poly-L-Lys,  223, (Phe, G)-A--L (16). Sheep erythrocytes were formalinized, 
tanned, and coated either with (T, G)-Pro---L or with (Phe, G)-A--L, as previously described 
(17). Passive microhemagglutination tests (18) were performed on disposable microtiter plates 
(Cooke Engineering Co., Alexandria, Va.) by 2-fold serial dilutions of antisera in phosphate- 
buffered saline (0.15 N NaC1, 0.01 M  phosphate buffer, pH 7) containing 0.1% bovine plasma 
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at 20°C and read at 2.5 hr and overnight. Separate hemagglutination assays were performed 
using (T, G)-Pro--L-coated and (Phe, G)-A--L-coated erythrocytes on the sera from indi- 
vidual recipient mice 12-14 days after immunization, i.e., at the time of maximum antibody 
titers (9). 
Statistical Methods.--The Poisson model was used to describe the theoretical probability 
that a given inoculum of 'donor-derived spleen cells would generate a significant detectable 
amount of anti-(Phe,  G) or anti-Pro--L serum in the irradiated recipients (14). The max- 
imum likelihood method was used to estimate  the probabilty values and  950-/0 confidence 
intervals (19). 
Frequency of Responses in Syngeneic Recipients Injected with Graded Numbers 
of Spleen  Cells from Immunized SJL and DBA/1 Donors.--Results  of earlier 
studies in which mice were immunized with  (Phe,  G)-Pro--L indicated that 
significant differences existed between the levels of secondary anti-(Phe, G) and 
anti-Pro--L responses in SJ-L and DBA/1 mice (5, 6). SJL mice were found to 
be high responders to Pro--L, but low responders to the (Phe, G) determinant 
of (Phe,  G)-Pro--L.  Conversely,  DBA/1  animals  were  high  responders  to 
(Phe, G), but low responders to the Pro--L portion of the irnmunogen. In cell 
transfer experiments, a 24-fold difference in the frequency of limiting precursor 
cells relevant for the  (T,  G)-Pro--L response was detected in spleens of im- 
munized SJL and DBA/1  donors, whereas a less  dramatic but significant dif- 
ference of 4-5-fold was observed using spleen cells from nonimmunized donors 
of these two strains (9). Therefore, in the present work, limiting dilution analy- 
ses were first performed using spleen cell suspensions from immunized SJL and 
DBA/1 donors in order to detect the maximum possible frequency differences 
of precursors limiting responsiveness to (Phe,  G)  and Pro--L. 
In repeated experiments a total of 116 SJ-L and 74 DBA/1 irradiated recipient 
mice were injected with graded numbers (1  X  105 --  4  X  l0  T) of spleen cells 
pooled from immunized syngeneic donors. Each  prospective donor had  been 
immunized intradermally 3  wk  before cell transfer with  10 #g  of  (Phe,  G)- 
Pro--L in complete Freund's adjuvant (9). Each recipient animal received an 
intravenous injection of spleen cells pooled from immunized donors mixed with 
10 pg of (Phe,  G)-Pro--L dissolved in Eagle's medium. The recipients were 
bled from the retro-orbital plexus at the time of peak antibody responses, i.e., 
12 days after cell transfer (9). 
The sera were individually assayed for antibodies specific for (Phe,  G)  and 
for Pro-'L by titering with (Phe, G)-A--L and (T, G)-Pro--L, respectively. 
Sera from control animals,  i.e.,  nonirradiated,  uninjected mice  or  irradiated 
mice injected with  antigen only, either exhibited no detectable antibodies  or 
gave responses detectable at a dilution not greater than 1:4. Therefore, sera of 
recipient  animals  were  considered  to  be  positive  or negative,  depending  on 
whether or not antibodies specific for (Phe, G)  and/or Pro--L were detected 
at dilutions of serum greater than  1:4. The results are presented in Tables I 
and II, and summarized graphically in Figs.  1 and 2. 
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TABLE  I 
Percentage of Positive Sera in Irradiated SJL Recipients 12 Days after Injection  of (Phe, G)- 
Pro--L  and  Graded Numbers  of Syngeneic  Spleen  Cells from  Immunized  Donors 
Percent- 
Number of Fraction  of  age of 
Sera of recipients  spleen  positive  positive  Probability  of positive  Precursor  cell 
titered with  ceils trans-  sera in"  sera in  sera per 106 cells:~  frequency (X 10-9 
planted  recipients*  recip- 
(X 106)  ients* 
(Phe, G)-A- -I,  o.1  0/8  0 
0.5  1/22  4.5 
1  2/18  11.1 
2  2/15  13.3 
5  6/22  27.3 
10  8/15  53.3 
40  11/16  68.8 
0.050  1/20 
(0.034  -  0.074)§  (1/13  -  1/29)§ 
(T,G)-Pro--L  0.1  1/8  12.5 
0.5  12/22  54.5 
1  14/18  77.8 
2  12/15  80.0 
5  21/22  95.5 
10  13/15  86.6 
40  16/16  100.0 
0.74  1/1.3 
(0.65  -  1.3)§  (1/0.77  -  1/1.5)§ 
* Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
Estimates of probability values were based on the Poisson model (19). 
§ 95% confidence intervals shown in parentheses. 
TABLE  II 
Percentage of Positive Sera in Irradiated DBA/1 Recipients  12 Days after Injection  of (Phe, 
G)-Pro--L  and  Graded Numbers  of Syngendc  Spleen  Cells from  Immunized  Donors 
Number  Fraction  Percentage 
Sera of recipients  of spleen  of posi-  of posi- 
titered with  cells trans-  tire sera  tive sera 
planted  in recipi-  in recipi- 
(X 106)  ents*  ents* 
Probability  of positive  Precursor  cell frequency 
sera per lO s cells+  +  (X  I0  -e) 
(Phe, G)-A- -L  0.5  2/7  28.6 
1  14/21  66.7 
2  7/7  100.0 
5  8/10  80.0 
10  12/13  92.4 
30  16/16  100.0 
0.58  1/1.7 
(0.38  -  0.87)§  (1/1.1  -  1/2.6)§ 
(T, G)-Pro-  -L  0.5  0/7  0 
1  3/21  14.3 
2  4/7  57.2 
5  4/10  40.0 
10  10/13  77.0 
30  14/16  87.5 
0.11  1/9.4 
(0.071  -  0.16)~  (1/6.2  -  1/14)§ 
*  Donor-derived responses showing titers at dilutions greater than  1:4 in recipient sera. 
Estimates of probability values were based on the Poisson model (19). 
§ 95% confidence intervals shown in parentheses. 220  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNE  RESPONSE 
for Pro--L in both mouse strains  as the num,er  ot  spleen cells injected was 
increased. As shown in Table I  for the Pro--L response, between 55  and 78 % 
positive SJL sera were obtained after injection of 0.5  --  1 >  106 spleen cells, 
whereas  an  equivalent  proportion  of sera were positive for the  (Phe,  G)  re- 
sponse only after injection of more than  10  X  106 spleen cells.  The inoculum 
size that  corresponded  to significant antibodies  detected  in  two-thirds  of the 
recipient sera was  10-40 times greater for the  (Phe,  G) determinant  than for 
Pro--L.  For a  more precise evaluation  (which  takes into  account  all inocula 
tested)  the  probability  values  that  106  spleen  cells  would  generate  positive 
(Phe,  G) or Prc~-L responses were estimated using the Poisson model and the 
method of maximum likelihood (19). The values for spleen cells from immunized 
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FIO.  1.  Percentage of positive sera in SJL  recipients when assayed with (Phe, G)-A- -L 
(symbol O) or (T, G)-Pro--L (symbol 0) after irradiation and injection  of (Phe, G)-Pro--L 
and graded numbers of spleen cells from immunized syngeneic donors. 
in  these probability values was statistically significant at the 0.05  level. The 
curves relating the number of cells injected to the frequencies of positive sera 
are shown in Fig.  1. In spleens of immunized SJL mice, one limiting precursor 
cell relevant for the Pro--L response was detected in  1.3  X  106 cells,  whereas 
one precursor was detected in 20  X  106 cells for the  (Phe,  G) response. It is 
noteworthy that  the  sera of all 30  animals which  were positive for (Phe,  G) 
were also positive for Pro--L. In contrast,  of the 89 sera which contained sig- 
nificant amounts of Pro--L antibodies, 59 did not exhibit demonstrable quan- 
tities of (Phe,  G)  antibodies. 
Table II presents the frequency data of responses for the two immunopotent 
portions of (Phe,  G)-Pro--L in spleens of immunized DBA/1 mice. Injections 
of 1 >  106 and 10 X  106 cells, respectively, were required to generate detectable 
(Phe,  G) and Pro--L responses in the sera of approximately two-thirds of the 
recipients.  Statistical  treatment  of the  data  as outlined  above indicated  that 
the  probability values  that  106 DBA/1  spleen  cells would  generate  (Phe,  G) 
or Pro--L  responses  were 0.58  and  0.11,  respectively. This  5-fold  difference G.  M.  SHEARER,  E.  MOZES~ AND  M.  SELA  221 
was significant. The limiting dilution curves for (Phe, G) and Pro--L responses 
in spleens of immunized DBA/1 donors are illustrated in Fig. 2. One limiting 
and relevant precursor for the  (Phe,  G) response and one for the Pro--L re- 
sponse were detected in 1.7  ×  10  ~ and in 9.4 X  106 spleen cells,  respectively. 
Sera of 32 of the 35 mice positive for Pro--L were also detected as positive for 
(Phe, G), whereas the sera of 27 of the 59 mice positive for (Phe, G) were not 
observed to be positive for Pro--L. 
Using (T, G)-A--L as a cross-reacting antigen, it was previously shown that 
the anti-(T, G)-Pro--L response was directed mainly against the Pro--L por- 
tion  of the  molecule  (5).  Therefore, it  was  of interest  to  establish  whether 
Pro--L  precursor  frequencies  would  be  similar  when  (T,  G)-Pro--L  or 
(Phe,  G)-Pro--L were used as the immunogens.  A  comparison of the results 
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FIG. 2. Percentage of positive sera in DBA/1 recipients  when assayed with (Phe, G)-A--L 
(symbol O) or (T, G)-Pro--L (symbol @) after irradiation and injection  of (Phe, G)-Pro--L 
and graded numbers of spleen cells from immunized syngeneic  donors. 
reported earlier (9), in which the immunogen was  (T, G)-Pro---L, with those 
presented  above,  in  which  the  immunogenic macromolecule was  (Phe,  G)- 
Pro--L, points to a discrepancy in the immunocompetent potential of DBA/1 
spleen cells which was not anticipated. Whereas the frequency of limiting pre- 
cursors detected in spleens of immunized DBA/1 donors was previously found 
to be  1/30 ×  10  6 ceils for (T,  G)-Pro--L  (9),  a  much higher frequency of 
1/9.4 ×  10  6 spleen cells was now observed for the Pro--L portion of (Phe, G)- 
Pro--L (Table II). Thus, although preimmunization did not alter the relative 
numbers of limiting precursors for (T, G)-Pro--L in the DBA/1 strain, there 
may have been an effect of priming on the Pro--L response when (Phe, G)- 
Pro--L was used as the immunizing agent. In other words, the anti-Pro--L 
response in boosted animals  appears to differ, depending  on whether the im- 
munogen contains  (Phe, Glu)  or (Tyr, GIn) attached to Pro--L. In order to 
investigate this possibility, additional limiting dilution studies were performed 
using spleen cell suspensions from nonimmunized SJL and DBA/1 donors. 
Frequency of Responses in Syngeneic Recipients Injected with Graded Numbers 222  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  IMMUNE  RESPONSE 
~f Spleen Cells from Nonimmunized  SJL  and DBA/1  Donors.--In  duplicate 
experiments,  83  SJ-L and  75  DBA/1  mice were irradiated  and injected  with 
graded inocula of cells (1  X  106 -- 4  X  l0  T) harvested from pooled spleens of 
nonimmunized syngeneic donors. 1 day later, the recipients were injected intra- 
peritoneally with 10 #g (Phe,  G)-Pro--L in complete Freund's adjuvant. Sera 
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FIG. 3. Percentage of positive sera in SJL recipients when assayed with (Phe, G)-A--L 
(symbol O) or (T, G)-Pro--L (symbol O) after irradiation and injection of (Phe, G)-Pro--L 
and graded numbers of spleen cells from nonimmunized syngeneic donors. 
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FIG. 4. Percentage of positive sera in DBA/1 recipients when assayed with (Phe, G)-A--L 
(symbol O) or (T, G)-Pro--L (symbol O) after irradiation and injection of (Phe, G)-Pro--L 
and graded numbers of spleen cells from nonimmunized syngeneic donors. 
taken from individual  recipients  14  days later were titered for (Phe,  G)  and 
Pro--L antibodies and  classified as positive or negative,  as described  above. 
The results are shown in Tables In  and IV and Figs. 3 and 4. As the number 
of inoculated spleen cells was increased, there was a  corresponding increase in 
the proportion of positive recipient sera titered with (Phe, G)-A--L and (T, G)- 
Pro--L in both strains. 
Approximately two-thirds of the sera of SJL mice were positive for Pro--L 
after injection of 5  X  106 spleen cells, whereas an equivalent fraction of sera 
positive for (Phe,  G) was detected only after injection of 20 X  106 cells (Table G.  M.  SHEARER,  E.  MOZES,  AND  ~[.  SELA  223 
III). The probability values that  106  inoculated  spleen  cells from nonimmu- 
nized  SJL  donors would  yield positive  (Phe,  G)  and Pro--L responses were 
calculated to be 0.049 and 0.30,  respectively. The corresponding limiting dilu- 
tion curves are shown in Fig.  3. The frequency of splenic precursors limiting 
the response for (Phe, G) was estimated to be 6-fold less than that for Pro--L. 
Unlike the results obtained with recipients of immunized SJL spleen cells,  8 of 
TABLE  III 
Percentage of Positive Sera in Irradiated SJL Recipients 14 Days after Injection of (Phe, G)- 
Pro- -L  and  Graded Numbers of Syngenelc Spleen Cells from  Nonimmunized  Donors 
Nunl- 
ber of  Fraction  Percentage 
Sera of recipients  spleen  of posi-  of posi-  titered with  ceils  tire sera  tive sera  Probability of positive  PrecurSor cell frequency 
trans-  in recipi-  in recipi-  sera per 106 cells~;  (X 10-6) 
planted  ents*  nts*  (× 106) 
(Phe, G)-A- -L  1  2/10  20.0 
2  3/12  25.0 
5  6/18  33.3 
10  7/13  53.8 
20  6/10  60.0 
40  16/20  80.0 
0.049  1/20 
(0.036 -  0.068)§  (1/15 -  1/28)§ 
(T, G)-Pro- -L  1  4/10  40.0 
2  7/12  58.2 
5  12/18  66.7 
10  12/13  92.3 
20  10/10  100.0 
40  18/20  90.0 
0.30  1/3.4 
(0.20 -  0.43)§  (1/2.3  -  1/4.9)§ 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
:~ Estimates of probability values based on Poisson model (19). 
§ 950-/0 confidence intervals shown in parentheses. 
the 40 sera positive for (Phe, G) did not show detectable anti-Pro--L activity 
in recipients of nonimmunized SJL spleen cells. 
Results of experiments using spleen cells from nonimmunized DBA/1 donors 
are presented in Table IV and Fig. 4. Estimates of the probability values per 
106 transferred cells were calculated to be 0.12 and 0.026 for the (Phe,  G) and 
Pro--L specificities, respectively. This 4.5-fold difference in limiting precursor 
frequency is illustrated in Fig. 4. 
The number of precursors necessary to generate an anti-Pro--L response in 
spleens of nonimmunized DBA/1  donors was 1 in 38 million, after immuniza- 
tion with (Phe, G)-Pro--L. This number is not significantly different from the 
frequency of  1  in  30-31  million,  obtained  upon  immunization  with  (T,  G)- 
Pro--L,  either  after transfer from nonimmunized  or from immunized donors 224  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  I1V[MUNE  RESPONSE 
(9). Thus, the anti-Pro--L response can indeed be increased in the  (Phe,  G)- 
Pro---L system, but not in the (T, G)-Pro--L system. 
18  of  the  19  sera  that  were  positive  for  the  Pro--L  specificity were  also 
positive for (Phe,  G),  whereas  23  of the total 41  (Phe,  G)-positive sera  were 
negative for Pro--L. 
Frequency  of Responses  in  Ft  Recipients  Injected  with  Graded  Numbers  of 
Spleen Cells from Immunized Syngeneic Donors.--In the results described above, 
TABLE IV 
Percentage of 2Posltive Sera in Irradiated DBA/1 Recipients 14 Days after Injection of (Phe 
G)-Pro- -L and Graded Numbers of Syngeneic Spleen Cells  from Nonlrnmunized Donors 
Number  Fraction  Percent- 
of spleen  of posi-  age of  Sera of recipients  ceils trans-  tire sern  positive  Probability of positive  Precursor cell 
titered with  planted  in recipi-  sera in  sera per 10 6 cells~  frequency  (X  10  -B) 
(X  l0 B)  eats*  recipients* 
(Phe, G)-A- -L 
(T, G)-Pro- -L 
O.5  2/14  14.3 
1  4/11  36.4 
2  7/14  50.0 
5  4/7  57.1 
10  3/4  75.0 
20  11/14  78.6 
40  10/11  91.0 
0.5  1/14  7.1 
1  0/11  0 
2  1/14  7.1 
5  2/7  28.6 
10  1/4  25.0 
20  7/14  50.0 
40  7/11  63.6 
0.12  1/8.5 
(0.076 -  0.18)§  (1/5.5  -  1/13)§ 
0.026  1/38 
(0.016 -  0.043)§  (1/23 -  1/62)§ 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
~: Estimates of probability values were based on the Poisson model (19). 
§ 95% confidence  intervals shown in parentheses. 
a  considerable proportion of DBA/1 sera were positive for (Phe, G), but nega- 
tive for Pro--L, whereas a  significant fraction of SJL sera  were  positive for 
Pro--L, but negative for (Phe,  G).  These  observations raise  the  question  of 
whether the relevant and limiting cell  types for (Phe,  G)  and for Pro--L are 
restricted to generating immune responses of a single  specificity. The responses 
of intact  (DBA/1  X  SJL)  F1 mice to (Phe,  G)  and Pro--L were found to be 
intermediate  between those of the  two parental  strains  (6).  Results  obtained 
in such studies indicated that separate populations of antibody molecules were 
synthesized to the  (Phe,  G)  and the Pr~--L parts of the imrnunogen. There- 
fore, by taking advantage of the fact that F~ animals respond well  to the two G.  M.  SHEARER~ E.  MOZES~ AND  M.  SELA  225 
TABLE V 
Percentage of Positive Sera in Irradiated  (DBA/1 X  SJL)F1 12 Days after Injection oJ (Phe, 
G)-Pro--L  and  Graded Numbers  of Syngeneic  Spleen  Cells from  Immunized  Donors 
Sera of recipients 
titered with 
Number 
of spleen  Fraction Percentage 
ceils  of positive  of positive Probability  of positive 
trans-  sera  In re-  sera  in re-  sera per 106 cells~ 
planted  cipients*  cipients* 
(X 10  6) 
Precursor cell frequency 
(X l0  -s) 
(Phe, G)-A--L  0.5  5/18  27.9 
1  4/14  28.6 
2  3/10  30.0 
3  6/15  40.0 
4  6/12  50.0 
8  9/11  81.8 
0.33  1/3.0 
(0.22  -  0.49)§  (1/2.0  -  1/4.5)§ 
(T, G)-Pro--L  0.5  3/18  16.7 
1  3/14  21.5 
2  3/10  30.0 
3  10/15  66.7 
4  7/12  58.3 
8  11/11  100.0 
0.36  1/2.8 
(0.25  -  0.53)§  (1/1.9  -  1/4.0)§ 
*  Donor-derived responses showing titers at dilutions greater than 1:4 in recipient sera. 
:~ Estimates of probability values were based on the Poisson model (19). 
§ 95% confidence intervals shown in parentheses. 
determinants of (Phe, G)-Pro--L, limiting dilution experiments and chi-square 
tests were performed in order to establish whether the responses to (Phe, G) 
and to Pro--L are independent. Irradiated F1 recipient mice were injected with 
(Phe, G)-Pro--L and graded numbers (0.5 --  8.0  X  106) of syngeneic spleen 
cells from immunized donors. The limiting dilution results are shown in Table V 
and Fig. 5. The frequencies of limiting precursors for (Phe, G) and for Pro--L 
were calculated to be 1/3.0 X  106 and 1/2.8 X  106, respectively. The probabil- 
Ioo 
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o-  ,~60 
5 4o 
~2o 
~.  o 
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FIG.  5.  Percentage of positive sera in F~  recipients when assayed with (Phe,  G)-A--L 
(symbol O) or (T, G)-Pro--L (symbol Q) after irradiation and injection  of (Phe, G)-Pro--L 
and graded numbers of spleen cells from immunized syngeneic donors. 226  CELLULAR  BASIS  OF  GENETIC  CONTROL  OF  I~MUNE  RESPONSE 
ity values were not  significantly different for responses  to  the  two determi- 
nants, and the 95 % confidence intervals overlapped. Since the frequency results 
for responses to  (Phe,  G)  and Pro--L were indistinguishable,  data from the 
range of cell inocula (0.5  -  4.0 X  106) that resulted in appreciable numbers of 
positive and negative recipient sera were combined and subjected to a ¥ates 
corrected chi-square test for independence of (Phe, G)  and Pro--L responses. 
Of the 79 sera considered, 9 were positive and 28 were negative for both speci- 
ficities.  15  sera  showed  antibody activity to  (Phe,  G),  but  not  to  Pro--L, 
whereas Pro--L specific antibodies were detected in 17 sera that did not show 
antibodies specific for (Phe, G). The calculated chi-square value was 0.1, well 
below the critical value of 3.84 at the 0.05 level of significance. This statistical 
result is in agreement with the notion that the splenic precursors limiting the 
response to (Phe, G) and Pro--L are independent. 
DISCUSSION 
The objectives of this study were: (a) to extend to another antigen the pre- 
vious  report  (9)  that  phenotypic  expression  of  genetic  control  to  synthetic 
polypeptide antigens is directly correlated to the number of immunocompetent 
responses detected; (b) to demonstrate this relationship for two separate anti- 
genic determinants on the same immunogen; and (c) to establish whether the 
responses to these two portions of the antigenic macromolecule are transferred 
independently. 
The estimated frequency of limiting spleen cell precursors specific for Pro--L 
from immunized SJL donors was 1/1.3  X  106 (Table I, Fig. 1), similar to that 
found for (T, G)-Pro--L in the same strain (9). As was expected from the low 
response of intact SJL mice to (Phe, G)  (6), the relative number of detected 
precursors was  1/20  X  106, 15 times below that of the Pro--L carried on the 
same immunogenic macromolecule. In contrast, the relative number of limiting 
precursors detected for (Phe,  G)  in  spleens  of immunized DBA/1  mice was 
1/1.7  X  106, 12  times higher  than  that  observed in  SJL  spleens  (Table II, 
Fig. 2). 
The frequency of precursors reactive with Pro--L observed in spleen cells 
from preimmunized DBA/1 donors was surprisingly high (1/9.4 X  106) when 
compared to that calculated for (T, G)-Pro--L (1/30 X  106) (9). These differ- 
ences indicate that significant changes can be seen in the frequency of precur- 
sors specific for a  given determinant when it is  part  of another immunogen. 
This could have been due to an initially greater number of precursors and/or 
to an increase in the number of precursors detected as a  result of immuniza- 
tion. Indeed, results of additional experiments (Table IV, Fig. 4) indicate that 
the frequency of Pro--L precursor cells in such spleens was 1/38 X  106, 4-fold 
lower  than  that  found  after  preimmunization  with  (Phe,  G)-Pro--L,  but 
similar to the frequency calculated for precursors in spleens of immunized or G.  M.  SHEARER,  E.  MOZES,  AND  M.  SELA  227 
nonimmunized DBA/1  donors when injected with (T,  G)-Pro--L. Although 
preimmunization had no detectable effect when  (T,  G)-Pro--L was the  im- 
munogen,  there was  a  significant increase in precursor frequency to Pro---L 
when (Phe, G)-Pro--L was used. Even though the short amino acid sequences 
attached to Pro--L do not determine in this case the specificity of the anti- 
bodies produced, they do influence the number of immunocompetent units re- 
sponding to the Pro--L determinant. 
For the  (Phe, G)  specificity, to which DBA/1  mice are high responders, a 
5-fold increase (1/1.7  X  10  6 vs. 1/8.5  X  10  6) in frequency was observed after 
preimmunizing the donors, whereas preimmunization had no detectable effect 
on  limiting  (Phe,  G)  precursor  frequency in  SJ-L mice--low  responders  to 
(Phe,  G). Preimmunization of SJL donors resulted in  a  slight  (2.6-fold) but 
significant increase  in  the  number  of Pro--L specific precursors (Table III, 
Fig. 3). 
The unequal frequencies of immunocompetent response units for the (Phe, G) 
and Pro--L specificities in the two parental strains raised the possibility that 
the limiting precursors for the two determinants may have been precommitted 
before  immunization.  The  striking  differences  observed  between  limiting 
(Phe, G) and Pro--L precursor frequencies in SJL and I)BA/1 spleens imply 
either that these cells were precommitted for the specificity before stimulation 
with immunogen, or that there was a preferential unidirectional commitment 
of a  noncommitted cell to  (Phe,  G)  in DBA/1  mice and  to Pro--L in  SJL 
mice at the time of immunization. If either of these possibilities were correct, 
then the response to the two specificities would be expected to be transferred 
to irradiated recipients independently.  Since in  the  parental strains  the  fre- 
quencies of responses were so different, it was not possible to test the dependence 
between (Phe, G) and Pro--L responses. The similar frequencies for the above 
responses  (1/3.0  X  10  6 and  1/2.8  X  10  6,  respectively)  obtained  using  F1 
spleens enabled us to investigate this question (Table V, Fig. 5). 
The finding that equal numbers of relevant spleen cells limiting the response 
to  (Phe,  G)  and Pro--L were detected in F1 mice could mean either that  a 
single cell type was  restricting the  response to the (Phe,  G)-Pro--L macro- 
molecule, or that two cells of equal frequency but of different specificities, i.e. 
(Phe,  G)  or Pro--L, were limiting the response. In other words, there could 
have been either a single dilution curve, which limited the response to the intact 
immunogen,  or there could have been a  superimposition of two curves,  one 
which limited the response to (Phe, G) and the other to Pro--L. The result of 
the chi-square test for independence of (Phe, G)  and Pro--L responses in F1 
mice is compatible with the latter possibility. Therefore, it is likely that the 
spleen cells limiting the response in these experiments were restricted to gen- 
erate antibodies specific for (Phe, G) or for Pro--L. 
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(Phe, G)-Pro--L (6), and since this report shows a direct correlation between 
responsiveness and  limiting  precursor frequency, as  well as  independence of 
(Phe, G) and Pro---L responses, it is possible to predict that phenotypic expres- 
sion  of  the  genetic  defect(s)  under  study  should  be  demonstrable  only  in 
lymphoid  tissues  which  exhibit  independence  of  responses  to  (Phe,  G)  and 
Pro--L. On the other hand, if a population of cells can be found which recog- 
nizes the intact  (Phe,  G)-Pro--L immunogen, then such a population should 
not reflect the  observed genetic defect. Studies are in progress to investigate 
the above hypothesis. 
SUMMARY 
DBA/1  mice are high responders to the  (Phe,  G)  determinant of the syn- 
thetic polypeptide (Phe,  G)-Pro--L, whereas SJL mice respond well to the 
Pro--L region of this macromolecule (6). In order to determine whether the 
phenomenon described above is related to the number of antigen-sensitive units 
detected for both specificities, and whether  responses  to  these  determinants 
can be transferred independently, graded and limiting inocula of spleen cells 
from SJL, DBA/1,  and F1 donors were injected into X-irradiated, syngeneic, 
recipient mice with (Phe, G)-Pro--L. 
By this  approach,  one antigen-sensitive unit specific for (Phe,  G)  was  de- 
tected in 1.7  >(  106 and 8.5  X  106 spleen cells from immunized and nonimnm- 
nized DBA/1 donors, respectively. In contrast, one (Phe, G) relevant precursor 
was detected in 20  )<  106 SJL spleen cells,  irrespective of whether the donors 
had been immunized. On the other hand, for the Pro--L specificity, one limiting 
splenic precursor was found in 1.3  X  106 and in 3.4 M  106 cells for immunized 
and nonimmunized SJL donors, respectively; whereas  one response unit was 
estimated for this determinant in 9.4 X  106 and in 38 )<  106 spleen cells from 
immunized and nonimmunized DBA/1  mice. The findings reported here indi- 
cate that  the phenotypic expression of the genetic control(s) for immune re- 
sponsiveness to different immunopotent regions of (Phe, G)-Pro--L is directly 
correlated with  the  number of immunocompetent response units  detected in 
two inbred mouse strains. 
In the spleens of immunized F1 donors, similar frequencies of one limiting 
precursor in 3.0  X  106 and in 2.8  X  l0  s cells were detected for (Phe, G)  and 
Pro--L,  respectively.  The results  of  a  chi-square  test  for  independence  of 
(Phe, G) and Pro--L responses in F1 animals is compatible with the hypothesis 
that the transferred spleen cells limiting the response to (Phe, G)-Pro--L are 
restricted to generate antibodies specific for only one of the two determinants 
of this macromolecule. 
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